TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
HALO

Halozyme Therapeutics Inc

Healthcare · Biotechnology

130.90$ -0.2% vs. previous close Closing price · As of: Oct 30, 2026

Statements

Income Statement

Halozyme Therapeutics Inc (HALO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,397 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HALO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
75 135 147 317 152 196 268 443 660 829 1,015 1,397
23 29 33 31 10 46 43 81 139 192 159 229
53 106 113 285 142 150 224 362 521 637 856 1,168
80 93 151 151 150 141 34 36 67 76 79 81
36 40 46 54 61 77 46 50 144 149 154 207
116 133 197 204 211 218 80 86 253 299 304 365
-63 -27 -83 81 -69 -68 144 276 268 338 551 803
5.6 5.2 20 22 18 12 20 7.5 17 19 18 18
-68 -32 -102 62 -80 -72 129 249 249 348 557 467
3.8 3.5 1.2 -1.4 0.5 0.0 0.2 -154 47 67 113 150
-68 -32 -103 63 -80 -72 129 403 202 282 444 317
-61 -26 -81 83 -67 -64 148 279 316 452 657 573

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?